The horizon should darken for Solvay in 2020. During the presentation of its annual results, the Belgian chemist warned that the uncertainties linked to the coronavirus, the stoppage of production of the Boeing 737 Max and the macroeconomic context should affect its results. The company estimates that its gross operating surplus should be stable or decrease slightly this year (up to -3%). The decline should be more marked in the first quarter (7 to 9%).
Regarding the coronavirus, " the total impact will depend on the duration of the epidemic, " said Solvay CEO Ilham Kadri, who has been in charge for almost a year. In the first quarter, Solvay anticipates a negative impact of around 25 million euros. And for good reason. The company generates 10% of its sales in China. However, production has restarted in its ten factories.
As for the Boeing 737 Max, its setbacks will also weigh on Solvay's accounts in 2020, which expects its profits to decrease by 30
This article is for subscribers only. You still have 69% to discover.
Subscribe: € 1 for 2 months
cancellable at any timeEnter your email
Already subscribed? Login